ARQT
Arcutis Biotherapeutics Inc
26.30$
-0.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | -641.4% | – | -91.4% | +464.5% | – | |
| – | -0.5% | -7.0% | -95.3% | +10,288.2% | -74.1% | +583.8% | -86.9% | +37.1% | +0.2% | -0.2% | +0.2% | – | |
| – | -12.4% | +14.5% | +24.9% | -21.9% | -4.0% | +4.1% | +7.3% | -4.3% | +0.2% | +6.3% | +19.4% | – | |
| – | – | -1,424.1% | – | – | – | – | – | -488.9% | – | – | -1,007.2% | – | |
| – | -90.6% | -100.0% | – | – | +3,396.5% | -87.8% | -87.2% | -100.0% | – | – | – | – | |
| – | -236.5% | -53.9% | +116.5% | – | -58.9% | -66.3% | +48.3% | -244.9% | +35.4% | -66.8% | +34.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +11,352.0% | +62.9% | -99.1% | -72.9% | -24,823.6% | – | +249.4% | +7.0% | +152.2% | -71.3% | +86.5% | – | |
| – | -909.2% | – | -204.4% | – | -225.6% | – | – | -232.6% | – | – | – | – | |
| – | – | – | – | – | – | – | – | -813.0% | – | -91.4% | +457.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.